Skip to main content

Find Clinical Trials

Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)

NCT00632073

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

NCT00736242

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +24 more
Locations: Not specified

View Trial Details

Completed

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

NCT00857298

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Body Weight, +27 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

NCT00594880

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Drexel University College of Medicine Philadelphia, Pennsylvania, United States

Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

Penn-Presbyterian Medical Center Philadelphia, Pennsylvania, United States

The Wistar Institute Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)

NCT00551018

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

NCT00705419

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Raltegravir Switch for Toxicity or Adverse Events

NCT00958100

Conditions: Acquired Immunodeficiency Syndrome, Antiretroviral Therapy, Blood-Borne Infections, +15 more
Locations: Policlinico A. Gemelli Rome, Italy

View Trial Details

Completed

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

NCT00849680

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

NCT00615134

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Aulnay-sous-Bois, France

Basse-terre, France

Bordeaux, France

Boulogne, France

View all 30 locations

View Trial Details

Completed

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

NCT00386633

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: LMU-Munich, Department of Infectious Diseases and Tropical Medicine Munich, Germany

View Trial Details